xaliproden has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andoh, T; Kuraishi, Y; Sakamoto, A | 2 |
2 other study(ies) available for xaliproden and Allodynia
| Article | Year |
|---|---|
Effects of xaliproden, a 5-HT₁A agonist, on mechanical allodynia caused by chemotherapeutic agents in mice.
Topics: Animals; Antineoplastic Agents; Gene Expression Regulation; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Naphthalenes; Pyridines; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Sensory Receptor Cells; Serotonin 5-HT1 Receptor Agonists; Tibial Nerve | 2013 |
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice.
Topics: Animals; Cell Movement; Hyperalgesia; Isoindoles; Male; Mast Cells; Mice; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Piperazines; Pyridines; Pyrimidines; Serotonin 5-HT1 Receptor Agonists; Skin | 2016 |